ECSafetyReporting object

Reportable AEs

SAE (Serious Adverse Event)
SUSAR (Suspected Unexpected Serious Adverse Reaction)

Investigator shall report SAE to

Sponsor

Reporting timeline

Immediately (without delay)

Responsible for AE reporting to relevant EC(s)

Sponsor

SUSAR being life-thereatening or leading to death must be reported

Within a max of 7d upon first knowledge (+ 8d for additional information)

All other SUSAR must be reported

Within a max of 15d upon first knowledge

Provision of Annual safety report mandatory

Yes

Guidance on AE reporting procedure

A detailed guideline on AE reporting obligations published by SUKL is available on the website:
“KLH-21 -Reporting Adverse Reactions to Medicinal Products for Human Use in a Clinical Trial and to Medicinal Products without Marketing Authorisation”

National legal framework in place

Yes

Applicable national legal framework/ Reference

Section 58(4)&(5) Act on Pharmaceuticals

Additional Information

ad Annual Safety Report: A summary of the Annual Safety Report provided to the CA has to be submitted to the local EC or the MEC only.

Feedback